Pemetrexed Plus Platinum for Patients With Advanced Non-small Cell Lung Cancer and Interstitial Lung Disease

Background/Aim: Pemetrexed plus platinum followed by pemetrexed maintenance has been one of the standard first-line treatments in advanced nonsquamous non-small cell lung cancer (NSCLC), but little is known regarding its safety and efficacy for patients with interstitial lung disease (ILD). Patients...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:In Vivo
Prif Awduron: FUJITA, TETSUO, KUROKI, TSUGUKO, HAYAMA, NAMI, SHIRAISHI, YUKA, AMANO, HIROYUKI, NAKAMURA, MAKOTO, HIRANO, SATOSHI, TABETA, HIROSHI, NAKAMURA, SUKEYUKI
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: International Institute of Anticancer Research 2019
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899148/
https://ncbi.nlm.nih.gov/pubmed/31662538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11704
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg